Michael R. Bishop to Recombinant Fusion Proteins
This is a "connection" page, showing publications Michael R. Bishop has written about Recombinant Fusion Proteins.
Connection Strength
0.025
-
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood. 2013 Dec 12; 122(25):4129-39.
Score: 0.025
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.